• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type 2 Diabetes.巨噬细胞大麻素-1受体信号在2型糖尿病中的发育作用
Diabetes. 2017 Apr;66(4):994-1007. doi: 10.2337/db16-1199. Epub 2017 Jan 12.
2
Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.足细胞中过度活跃的大麻素1受体驱动2型糖尿病肾病。
Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):E5420-8. doi: 10.1073/pnas.1419901111. Epub 2014 Nov 24.
3
Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes.内源性大麻素激活浸润巨噬细胞中的 Nlrp3 炎性小体导致 2 型糖尿病β细胞丢失。
Nat Med. 2013 Sep;19(9):1132-40. doi: 10.1038/nm.3265. Epub 2013 Aug 18.
4
Absence of cannabinoid 1 receptor in beta cells protects against high-fat/high-sugar diet-induced beta cell dysfunction and inflammation in murine islets.β细胞中缺乏大麻素 1 受体可防止高脂肪/高糖饮食诱导的胰岛β细胞功能障碍和炎症。
Diabetologia. 2018 Jun;61(6):1470-1483. doi: 10.1007/s00125-018-4576-4. Epub 2018 Mar 1.
5
Repetitive Intermittent Hyperglycemia Drives the M1 Polarization and Inflammatory Responses in THP-1 Macrophages Through the Mechanism Involving the TLR4-IRF5 Pathway.反复间歇性高血糖通过 TLR4-IRF5 通路机制驱动 THP-1 巨噬细胞的 M1 极化和炎症反应。
Cells. 2020 Aug 12;9(8):1892. doi: 10.3390/cells9081892.
6
Voluntary running exercise prevents β-cell failure in susceptible islets of the Zucker diabetic fatty rat.自愿跑步运动可预防 Zucker 糖尿病肥胖大鼠易感胰岛β细胞衰竭。
Am J Physiol Endocrinol Metab. 2012 Jan 15;302(2):E254-64. doi: 10.1152/ajpendo.00360.2011. Epub 2011 Nov 1.
7
Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans.药物靶向大麻素受体 1 可影响免疫细胞和胰岛之间的串扰,从而减少人类的胰岛炎。
Diabetologia. 2024 Sep;67(9):1877-1896. doi: 10.1007/s00125-024-06193-6. Epub 2024 Jun 12.
8
Cannabinoid receptor 1 disturbance of PPARγ2 augments hyperglycemia induction of mesangial inflammation and fibrosis in renal glomeruli.大麻素受体1对PPARγ2的干扰增强了肾小球系膜炎症和纤维化的高血糖诱导作用。
J Mol Med (Berl). 2014 Jul;92(7):779-92. doi: 10.1007/s00109-014-1125-6. Epub 2014 Apr 11.
9
Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes.棕榈酸诱导人胰腺胰岛产生炎症反应,这种反应模拟了 2 型糖尿病中β细胞的 CCL2 表达。
Diabetologia. 2010 Jul;53(7):1395-405. doi: 10.1007/s00125-010-1707-y. Epub 2010 Apr 6.
10
Macrophage alterations in islets of obese mice linked to beta cell disruption in diabetes.肥胖小鼠胰岛中巨噬细胞的改变与糖尿病中β细胞破坏有关。
Diabetologia. 2019 Jun;62(6):993-999. doi: 10.1007/s00125-019-4844-y. Epub 2019 Mar 4.

引用本文的文献

1
The intervention of cannabinoid receptor in chronic and acute kidney disease animal models: a systematic review and meta-analysis.大麻素受体在慢性和急性肾病动物模型中的干预作用:一项系统评价和荟萃分析。
Diabetol Metab Syndr. 2024 Feb 15;16(1):45. doi: 10.1186/s13098-024-01283-2.
2
An Integrative Multiomics Framework for Identification of Therapeutic Targets in Pulmonary Fibrosis.一种综合多组学框架,用于鉴定肺纤维化的治疗靶点。
Adv Sci (Weinh). 2023 Jun;10(16):e2207454. doi: 10.1002/advs.202207454. Epub 2023 Apr 10.
3
Optimization of the Heterologous Expression of the Cannabinoid Type-1 (CB) Receptor.大麻素受体 1(CB1)的异源表达优化。
Front Endocrinol (Lausanne). 2021 Oct 20;12:740913. doi: 10.3389/fendo.2021.740913. eCollection 2021.
4
Peripheral Hybrid CBR and iNOS Antagonist MRI-1867 Displays Anti-Fibrotic Efficacy in Bleomycin-Induced Skin Fibrosis.外周混合型 CBR 和 iNOS 拮抗剂 MRI-1867 在博来霉素诱导的皮肤纤维化中显示出抗纤维化疗效。
Front Endocrinol (Lausanne). 2021 Sep 28;12:744857. doi: 10.3389/fendo.2021.744857. eCollection 2021.
5
An Autonomous Cannabinoid System in Islets of Langerhans.胰岛中的自主大麻素系统。
Front Endocrinol (Lausanne). 2021 Jul 5;12:699661. doi: 10.3389/fendo.2021.699661. eCollection 2021.
6
Endocannabinoids in immune regulation and immunopathologies.内源性大麻素在免疫调节和免疫病理中的作用。
Immunology. 2021 Oct;164(2):242-252. doi: 10.1111/imm.13378. Epub 2021 Jul 8.
7
Cannabinoid receptors are differentially regulated in the pancreatic islets during the early development of metabolic syndrome.大麻素受体在代谢综合征早期发展过程中胰岛的调节存在差异。
Islets. 2020 Nov 1;12(6):134-144. doi: 10.1080/19382014.2020.1849927. Epub 2020 Dec 8.
8
The Neuroimmunology of Chronic Pain: From Rodents to Humans.慢性疼痛的神经免疫学:从啮齿动物到人。
J Neurosci. 2021 Feb 3;41(5):855-865. doi: 10.1523/JNEUROSCI.1650-20.2020. Epub 2020 Nov 25.
9
Signaling through the type 2 cannabinoid receptor regulates the severity of acute and chronic graft-versus-host disease.通过 2 型大麻素受体信号转导调节急性和慢性移植物抗宿主病的严重程度。
Blood. 2021 Mar 4;137(9):1241-1255. doi: 10.1182/blood.2020004871.
10
Inhibition of hsa_circ_0002570 suppresses high-glucose-induced angiogenesis and inflammation in retinal microvascular endothelial cells through miR-1243/angiomotin axis.hsa_circ_0002570 的抑制作用通过 miR-1243/angiomotin 轴抑制高糖诱导的视网膜微血管内皮细胞血管生成和炎症反应。
Cell Stress Chaperones. 2020 Sep;25(5):767-777. doi: 10.1007/s12192-020-01111-2. Epub 2020 Apr 21.

本文引用的文献

1
Mice lacking GPR3 receptors display late-onset obese phenotype due to impaired thermogenic function in brown adipose tissue.缺乏GPR3受体的小鼠由于棕色脂肪组织产热功能受损而表现出迟发性肥胖表型。
Sci Rep. 2015 Oct 12;5:14953. doi: 10.1038/srep14953.
2
The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metabolic Disease.内源性大麻素系统:肥胖症和代谢性疾病的关键协调器。
Trends Endocrinol Metab. 2015 Oct;26(10):524-537. doi: 10.1016/j.tem.2015.07.007.
3
Structural Basis of Species-Dependent Differential Affinity of 6-Alkoxy-5-Aryl-3-Pyridinecarboxamide Cannabinoid-1 Receptor Antagonists.6-烷氧基-5-芳基-3-吡啶甲酰胺类大麻素-1受体拮抗剂物种依赖性差异亲和力的结构基础
Mol Pharmacol. 2015 Aug;88(2):238-44. doi: 10.1124/mol.115.098541. Epub 2015 May 26.
4
Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity.巨噬细胞中 Irf5 的缺失促进肥胖期间有益的脂肪组织扩张和胰岛素敏感性。
Nat Med. 2015 Jun;21(6):610-8. doi: 10.1038/nm.3829. Epub 2015 May 4.
5
Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.足细胞中过度活跃的大麻素1受体驱动2型糖尿病肾病。
Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):E5420-8. doi: 10.1073/pnas.1419901111. Epub 2014 Nov 24.
6
Selective inhibition of 12-lipoxygenase protects islets and beta cells from inflammatory cytokine-mediated beta cell dysfunction.12-脂氧合酶的选择性抑制可保护胰岛和β细胞免受炎性细胞因子介导的β细胞功能障碍。
Diabetologia. 2015 Mar;58(3):549-57. doi: 10.1007/s00125-014-3452-0. Epub 2014 Nov 23.
7
Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy.非髓系来源细胞中的Nlrp3炎性小体激活会加重糖尿病肾病。
Kidney Int. 2015 Jan;87(1):74-84. doi: 10.1038/ki.2014.271. Epub 2014 Jul 30.
8
The alteration of Th1/Th2/Th17/Treg paradigm in patients with type 2 diabetes mellitus: Relationship with diabetic nephropathy.2型糖尿病患者Th1/Th2/Th17/Treg模式的改变:与糖尿病肾病的关系
Hum Immunol. 2014 Apr;75(4):289-96. doi: 10.1016/j.humimm.2014.02.007. Epub 2014 Feb 12.
9
Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes.内源性大麻素激活浸润巨噬细胞中的 Nlrp3 炎性小体导致 2 型糖尿病β细胞丢失。
Nat Med. 2013 Sep;19(9):1132-40. doi: 10.1038/nm.3265. Epub 2013 Aug 18.
10
The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders.内源性大麻素系统在能量平衡和代谢紊乱的发病机制中的作用。
Cell Metab. 2013 Apr 2;17(4):475-90. doi: 10.1016/j.cmet.2013.03.001.

巨噬细胞大麻素-1受体信号在2型糖尿病中的发育作用

Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type 2 Diabetes.

作者信息

Jourdan Tony, Szanda Gergő, Cinar Resat, Godlewski Grzegorz, Holovac David J, Park Joshua K, Nicoloro Sarah, Shen Yuefei, Liu Jie, Rosenberg Avi Z, Liu Ziyi, Czech Michael P, Kunos George

机构信息

Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD

Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD.

出版信息

Diabetes. 2017 Apr;66(4):994-1007. doi: 10.2337/db16-1199. Epub 2017 Jan 12.

DOI:10.2337/db16-1199
PMID:28082458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5360301/
Abstract

Islet inflammation promotes β-cell loss and type 2 diabetes (T2D), a process replicated in Zucker Diabetic Fatty (ZDF) rats in which β-cell loss has been linked to cannabinoid-1 receptor (CBR)-induced proinflammatory signaling in macrophages infiltrating pancreatic islets. Here, we analyzed CBR signaling in macrophages and its developmental role in T2D. ZDF rats with global deletion of CBR are protected from β-cell loss, hyperglycemia, and nephropathy that are present in ZDF littermates. Adoptive transfer of CBR bone marrow to ZDF rats also prevents β-cell loss and hyperglycemia but not nephropathy. ZDF islets contain elevated levels of CBR, interleukin-1β, tumor necrosis factor-α, the chemokine CCL2, and interferon regulatory factor-5 (IRF5), a marker of inflammatory macrophage polarization. In primary cultured rodent and human macrophages, CBR activation increased expression, whereas knockdown of blunted CBR-induced secretion of inflammatory cytokines without affecting CCL2 expression, which was p38MAPKα dependent. Macrophage-specific in vivo knockdown of protected ZDF rats from β-cell loss and hyperglycemia. Thus, IRF5 is a crucial downstream mediator of diabetogenic CBR signaling in macrophages and a potential therapeutic target.

摘要

胰岛炎症会促进β细胞丢失和2型糖尿病(T2D),这一过程在Zucker糖尿病肥胖(ZDF)大鼠中也会出现,其中β细胞丢失与浸润胰腺胰岛的巨噬细胞中大麻素1受体(CBR)诱导的促炎信号有关。在此,我们分析了巨噬细胞中的CBR信号及其在T2D中的发育作用。CBR全球缺失的ZDF大鼠可免受ZDF同窝仔鼠所出现的β细胞丢失、高血糖和肾病的影响。将CBR骨髓过继转移至ZDF大鼠也可预防β细胞丢失和高血糖,但不能预防肾病。ZDF胰岛中CBR、白细胞介素-1β、肿瘤坏死因子-α、趋化因子CCL2和干扰素调节因子-5(IRF5,炎症性巨噬细胞极化的标志物)水平升高。在原代培养的啮齿动物和人类巨噬细胞中,CBR激活会增加 的表达,而敲低 会减弱CBR诱导的炎性细胞因子分泌,但不影响CCL2的表达,CCL2的表达依赖于p38MAPKα。巨噬细胞特异性体内敲低 可保护ZDF大鼠免受β细胞丢失和高血糖的影响。因此,IRF5是巨噬细胞中致糖尿病CBR信号的关键下游介质和潜在治疗靶点。